Dr. Douglas Scott Hamblin, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 605 Welch St, Silverton, OR 97381 Phone: 503-782-1975 Fax: 503-343-6232 |
News Archive
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), signs up Healthcare Associates (www.healthcareasscociates.com) to its growing list of medical subscribers.
The United Kingdom government has selected the city of Sheffield to participate in a three-month pilot program aimed at increasing HIV detection rates by offering home-based test kits, the Sheffield Star reports.
The drug flibanserin, which was originally created as an antidepressant, is effective in treating women with low libido, pooled results from three separate clinical trials have found.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that clinical trial results on epratuzumab, the anti-CD22 humanized monoclonal antibody licensed to UCB SA, Brussels, for autoimmune disease indications, from the Phase IIb study in patients with lupus, will be presented in four posters sessions and one published abstract.
New clues about the bacteria that cause Lyme disease could lead to a novel strategy to reduce infections, according to a study to be published in mBio-, the online open-access journal of the American Society for Microbiology, on December 4.
› Verified 6 days ago